Charles Dunn - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Charles Dunn’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Patient Care,
- Health Care,
- Wellness,
- Fundraising,
- Investment Management,
- Healthcare Innovation,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Venture Fundraising,
- Finance,
- Biotechnology,
- Medical Devices,
- Precision Medicine,
- Neuropsychiatric Disorders,
- Innovation,
- Clinical Trials,
- Human Capital,
- Gene Therapy,
- Personalized Medicine,
- Telehealth,
- Mergers and Acquisitions,
- UK-based Startups,
- Digital Health,
- Medical,
- Information Technology,
- B2B,
- Therapeutics,
- Financial Advisory,
- Health Tech,
- Cellular Therapy,
- Media and Entertainment,
- Healthcare Technology,
- Risk Management,
- Acquisitions
Social media:
Past investments:
- Enara Bio
- Pulmocide
- Zarodex
- Prilenia
- Imbria Pharmaceuticals
- Autifony Therapeutics
- Draig Therapeutics
- Mestag Therapeutics
- Quell Therapeutics
Investor Profile
Charles Dunn is a Venture Capital, Private Equity Firm, Investor based in United Kingdom with a diverse investment portfolio that includes companies such as Enara Bio, Pulmocide, Zarodex, Prilenia, Imbria Pharmaceuticals, Autifony Therapeutics, Draig Therapeutics, Mestag Therapeutics, Quell Therapeutics. Over time, Charles Dunn has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Charles Dunn is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wellness, Fundraising, Investment Management, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Venture Fundraising, Finance, Biotechnology, Medical Devices, Precision Medicine, Neuropsychiatric Disorders, Innovation, Clinical Trials, Human Capital, Gene Therapy, Personalized Medicine, Telehealth, Mergers and Acquisitions, UK-based Startups, Digital Health, Medical, Information Technology, B2B, Therapeutics, Financial Advisory, Health Tech, Cellular Therapy, Media and Entertainment, Healthcare Technology, Risk Management, Acquisitions may find it worthwhile to explore potential connections with Charles Dunn, as their portfolio suggests a familiarity and interest in this area.
Understanding Charles Dunn’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
